Facebook
Twitter
LinkedIn
ForwardMarch 26, 2024 MGB APP Grand Rounds and Pharmacology Series 2023-2024: Seizure Management - Archived
Description
This activity provides on-demand archived lectures from the Grand Rounds and Pharmacology Series 2023-2024.. This educational bi-monthly series is designed to provide clinical content that is relevant to multiple disciplines throughout the Mass General Brigham organization. The lectures are designed to provide concise and accurate information that clinicians can use to provide evidence-based care. The lectures have been designed based on feedback from community members.
Course Directors:
Erin Schroeder, NP & Ariel Nowicki, PA-C
For questions regarding the registration process, please contact Mass General Brigham Office of Continuing Professional Development at partnerscpd@partners.org.
You may print individual certificates throughout the year; your cumulative list of completed activities is accessible on your transcript.
Target Audience
This activity is intended for APPs (PAs, NPs), MDs, Pharmacists within Mass General Brigham
Learning Objectives
Upon completion of this activity, participants will be able to:
- Assess the most up to date diagnostic and therapeutic modalities and innovations in care of the patients who are of populations/with conditions discussed in this series
- Identify subspecialty provider teams to collaborate with regarding medically complex patients
- Summarize signs and symptoms of patients with various conditions discussed in this series, such as neurological and rheumatologic disorders
- Identify the most up to date and evidence-based treatments for substance use disorders
- Identify key tenets of antimicrobial stewardship
Additional Information
Provided by Mass General Brigham
Course Directors
Erin Schroeder, CNP
Nurse Practitioner, Gynecologic Oncology,
Massachusetts General Hospital
Ariel Nowicki, PA-C
Neurosurgery ICU Physician Assistant,
Brigham and Women's Hospital
Faculty
Daniel Harrison, MD
DISCLOSURE SUMMARY OF RELEVANT FINANCIAL RELATIONSHIPS
MITIGATION STRATEGIES
Mass General Brigham has implemented a process to mitigate relevant financial relationships for this continuing education (CE) activity to help ensure content objectivity, independence, fair balance and ensure that the content is aligned with the interest of the public.
The following planners reported no relevant financial relationship with an ineligible company:
Marcela del Carmen
Jessica McCarthy
Ariel Nowicki PA-C
Darlene Sawicki
Michael Schontz, PharmD
Erin Schroeder NP
Elizabeth Woods
The following speakers have reported a relevant financial relationships with an ineligible company:
Daniel Harrison, MD
Consultant: Glass Health, Scientia Imaging
Advisory Board: Azurity pharmaceuticals – ended
ACCREDITATION
In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statements
AMA PRA Category 1 CreditTM
Mass General Brigham designates this live activity for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacy
This activity provides 1 contact hours (1 CEU) of continuing education credit. ACPE Universal Activity Number (UAN): JA0007437-0000-24-042-H04-P
Pharmacy Technicians
This activity provides 1 contact hours (1 CEU) of continuing education credit. ACPE Universal Activity Number (UAN): JA0007437-0000-24-042-H04-t
This offering carries 1.0 Pharmacotherapeutic contact hours
Available Credit
- 1.00 ACPE Pharmacy
- 1.00 ACPE Technician
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation